Treatment of noninfarct-related cardiogenic shock;Therapie des nichtinfarktbedingten kardiogenen Schocks

Intensivmedizin und Notfallmedizin

Volumn 48, Issue 4, 2011, Pages 259-263

  Geppert, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Heart assist devices; Inotropic agents, positive cardiac; Myocarditis; Valvular dysfunction; Valvuloplasty

Indexed keywords

EID: 79956227572     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-010-0235-9     Document Type: Article

References (28)

1. Hochman JS, Sleeper LA, Webb JG et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341: 625-634.
2. Hochman JS, Buller CE, Sleeper LA et al (2000) Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome: A report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shocK? J Am Coll Cardiol 36: 1063-1070.
3. Nieminen MS, Harjola VP, Hochadel M et al (2008) Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 10: 140-148.
4. Cotter G, Moshkovitz Y, Milovanov O et al (2002) Acute heart failure: A novel approach to its pathogenesis and treatment. Eur J Heart Fail 4: 227-234.
5. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
6. Antman EM, Anbe DT, Armstrong PW et al (2004) ACC/AHA Guidelines for the Management of Patients with ST-elevation Myocardial Infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110: e82-e292.
7. De Backer D, Biston P, Devriendt J et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362: 779-789.
8. Duranteau J, Sitbon P, Teboul JL et al (1999) Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27: 893-900.
9. Annane D, Vignon P, Renault A et al (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet 370: 676-684.
10. Myburgh JA, Higgins A, Jovanovska A et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34: 2226-2234.
11. Alexander JH, Reynolds HR, Stebbins AL et al (2007) Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial. JAMA 297: 1657-1666.
12. Thompson CR, Buller CE, Sleeper LA et al (2000) Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: A report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries in cardiogenic shock? J Am Coll Cardiol 36: 1104-1109.
13. Khot UN, Novaro GM, Popovic ZB et al (2003) Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348: 1756-1763.
14. Folland ED, Kemper AJ, Khuri SF et al (1985) Intraaortic balloon counterpulsation as a temporary support measure in decompensated critical aortic stenosis. J Am Coll Cardiol 5: 711-716.
15. Gu YL, Jessurun GA, Merkhof LF van den, Zijlstra F (2007) Intra-aortic balloon counterpulsation for complex aortic stenosis in hybrid strategy. Int J Cardiol 117: e46-e48.
16. Aksoy O, Yousefzai R, Singh D et al (2010) Cardiogenic shock in the setting of severe aortic stenosis: Role for intra-aortic balloon pump support. Heart Oct 20 (epub ahead of print).
17. Loebe M, Zade Asfahani WH, Petrov GP et al (2009) Surgical considerations on the use of the percutaneous ventricular assist device TandemHeart in critical aortic valve stenosis. Thorac Cardiovasc Surg 57: 50-52.
18. Frank CM, Palanichamy N, Kar B et al (2006) Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis. Tex Heart Inst J 33: 487-489.
19. Hamid T, Eichhofer J, Clarke B, Mahadevan VS (2010) Aortic balloon valvuloplasty: Is there still a role in high-risk patients in the era of percutaneous aortic valve replacement? J Interv Cardiol 23: 358-361.
20. Doguet F, Godin M, Lebreton G et al (2010) Aortic valve replacement after percutaneous valvuloplasty - an approach in otherwise inoperable patients. Eur J Cardiothorac Surg 38: 394-399.
21. Chatterjee K, Parmley WW, Swan HJ et al (1973) Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 48: 684-690.
22. Heuser RR, Maddoux GL, Goss JE et al (1987) Coronary angioplasty for acute mitral regurgitation due to myocardial infarction. A nonsurgical treatment preserving mitral valve integrity. Ann Intern Med 107: 852-855.
23. Shawl FA, Forman MB, Punja S, Goldbaum TS (1989) Emergent coronary angioplasty in the treatment of acute ischemic mitral regurgitation: Long-term results in five cases. J Am Coll Cardiol 14: 986-991.
24. Bonow RO, Carabello BA, Chatterjee K et al (2008) Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52: e1-e142.
25. Hoefer D, Jonetzko P, Hoermann C et al (2006) Successful administration of levosimendan in a patient with low-gradient low-output aortic stenosis. Wien Klin Wochenschr 118: 60-62.
26. Olimulder MA, Es J van, Galjee MA (2009) The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy. Neth Heart J 17: 481-486.
27. Dennert R, Crijns HJ, Heymans S (2008) Acute viral myocarditis. Eur Heart J 29: 2073-2082.
28. Poelzl G, Frick M, Antretter H et al (2006) Interventional and medical treatment of acute heart failure due to inflammation: Four cases. Herz 31: 761-766.